Bharat, Serum Institute ramp up production of their swine flu vaccines

Two Indian vaccinemakers are ramping up production of their swine flu vaccines, to replace stocks that were destroyed recently after they expired. Bharat Biotech and Serum Institute are both hustling to get tens of thousands of doses to the market within weeks as swine flu has surged through. About 11,000 people have tested positive and 750 have died. Report

Suggested Articles

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

The FDA hit New Jersey-based CMO Tris Pharma with a warning letter, citing significant violations.

Celltrion remains optimistic it will get U.S. approval for its two biosimilar drugs, Rituxan and Herceptin, by the end of the year.